Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer

BACKGROUND: Enzalutamide is a novel antiandrogen with proven efficacy in metastatic castration-resistant prostate cancer (mCRPC). OBJECTIVE: To evaluate enzalutamide’s effects on cancer and on androgens in blood and bone marrow, and associate these with clinical observations. DESIGN, SETTING, AND PA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol
Main Authors: Efstathiou, Eleni, Titus, Mark, Wen, Sijin, Hoang, Anh, Karlou, Maria, Ashe, Robynne, Tu, Shi Ming, Aparicio, Ana, Troncoso, Patricia, Mohler, James, Logothetis, Christopher J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4247811/
https://ncbi.nlm.nih.gov/pubmed/24882673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.05.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados